삼아제약: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of 삼아제약, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Market capitalisation: €98.9bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 삼아제약. Every trade is accessible without an account.